Medical Developments International (MVP) Short Interest
Medical Developments International (ASX:MVP) had 0.00% of shares reported as short positions as of 24 Aug 2026, representing 152 shares. Medical Developments International operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Medical Developments International
Medical Developments International (MVP) is a pharmaceutical company focused on developing and distributing innovative medical devices. They operate in the acute pain and respiratory illness treatment sectors, aiming to improve patient care globally. MDI partners with organizations like CSIRO to drive industry-leading product development.
Short position
Medical Developments International (ASX:MVP) has 0.00% of its shares on issue reported as short positions as of 24 Aug 2026, or about 152 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 2.53% in September 2021. MVP is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4MVP intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Medical Developments International
Latest MVP news
All news- Imricor Medical Systems and Philips launch MR-guided cardiac interventions lab
motleyfool
- Medical Developments International Builds Penthrox Momentum on Improved Cash Flow
smallcaps
- Storm enforcer Kamikamica forced into medical retirement after stroke
abc
- MVP Announces FY26 Full Year Results
asx
- FY26 Full year Results Investor Presentation
asx
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss MVP
Start a research thread or post the first pulse update